Answers are grounded in this paper and cite their sources.
The majority of experimental approaches for cancer immunotherapy are tested against relatively small tumors in tumor-bearing mice, because in most cases advanced cancers are resistant to the treatments. In this study, we asked if even late-stage mouse tumors can be eradicated by a rationally designed combined radio-immunotherapy (CRI) regimen.
No takes yet. Share an insight, caveat, or question.
Rakhmilevich et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: